Autres langues

17/08 Acarix (Q2 Review): Laying the groundwork
13/08 Acarix AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
13/08 Acarix (Q2 Initial take): In line with estimates
13/08 Acarix Publishes Second Quarter and First Half 2026 Results
11/08 Acarix Receives Regulatory Approval for the CADScor(R) System in the UAE (United Arab Emirates)
10/08 Acarix Receives Regulatory Approval For The CADScor System In The UAE
10/08 Acarix Receives UAE Clearance for Point-of-Care Diagnostic Aid
10/08 Acarix Receives Regulatory Approval for the CADScor®System in the United Arab Emirates
17/06 Acarix AB Announces Directorate Appointments
17/06 Announcement from the annual general meeting in Acarix AB
16/06 Proposals of the Nomination Committee for the Annual General Meeting of Acarix AB (publ) on June 17, 2026
16/06 Acarix AB Announces That Marlou Janssen-Counott Declines Re-Election as A Member of the Board of Directors
19/05 Acarix (Q1 Review): Continued US traction and improved cost base
19/05 Acarix : Notice AGM 2029 (ENG) (Notice Acarix AB final 2026 05 1818540034)
18/05 NOTICE OF ANNUAL GENERAL MEETING IN ACARIX AB
18/05 Acarix : Q1 2026 (Acarix Q12026 English Report 2605150747 FINAL)
18/05 Acarix Publishes Interim Report, January – March 2026
18/05 Acarix AB Reports Earnings Results for the First Quarter Ended March 31, 2026
04/05 Acarix Changes Publication Date for Q1 2026 Interim Report
15/04 Acarix AB’s Annual Report 2025
15/04 Acarix : 2025 ANNUAL REPORT-ENGLISH (Acarix English Annual 2025 Report Final)
15/04 Acarix AB Auditor Raises 'Going Concern' Doubt
08/04 ACARIX PRESENTS ABSTRACT AT ACC.26 HIGHLIGHTING CADSCOR® SYSTEM'S DIAGNOSTIC UTILITY COMPARED TO STANDARD STRESS TESTS IN CHEST PAIN PATIENTS
13/02 Acarix (Q4 review): A solid end to 2025
12/02 Acarix Publishes Year-End Report 2025
Aucun résultat pour cette recherche